Literature DB >> 26355087

Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.

Sarah R Jacobs1, Charles M Stopford1, John A West1, Christopher L Bennett1, Louise Giffin1, Blossom Damania2.   

Abstract

UNLABELLED: Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus known to establish lifelong latency in the human host. We and others have previously shown that three KSHV homologs of cellular interferon regulatory factors (IRFs), known as viral IRFs (vIRFs), participate in evasion of the host interferon (IFN) response. We report that vIRF1 interacts with the cellular interferon-stimulated gene 15 (ISG15) E3 ligase, HERC5, in the context of Toll-like receptor 3 (TLR3) activation and IFN induction. The ISG15 protein is covalently conjugated to target proteins upon activation of the interferon response. Interaction between vIRF1 and HERC5 was confirmed by immunoprecipitation, and the region between amino acids 224 and 349 of vIRF1 was required for interaction with HERC5. We further report that expression of vIRF1 in the context of TLR3 activation results in decreased ISG15 conjugation of proteins. Specifically, TLR3-induced ISG15 conjugation and protein levels of cellular IRF3, a known ISG15 target, were decreased in the presence of vIRF1 compared to the control. vIRF1 itself was also identified as a target of ISG15 conjugation. KSHV-infected cells exhibited increased ISG15 conjugation upon reactivation from latency in coordination with increased IFN. Furthermore, knockdown of ISG15 in latently infected cells resulted in a higher level of KSHV reactivation and an increase in infectious virus. These data suggest that the KSHV vIRF1 protein affects ISG15 conjugation and interferon responses and may contribute to effective KSHV replication. IMPORTANCE: The KSHV vIRF1 protein can inhibit interferon activation in response to viral infection. We identified a cellular protein named HERC5, which is the major ligase for ISG15, as a vIRF1 binding partner. vIRF1 association with HERC5 altered ISG15 modification of cellular proteins, and knockdown of ISG15 augmented reactivation of KSHV from latency.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355087      PMCID: PMC4645652          DOI: 10.1128/JVI.01482-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein.

Authors:  J L Potter; J Narasimhan; L Mende-Mueller; A L Haas
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

2.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells.

Authors:  Chen Zhao; Tien-Ying Hsiang; Rei-Lin Kuo; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

4.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

Authors:  Chen Zhao; Carilee Denison; Jon M Huibregtse; Steven Gygi; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

5.  Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.

Authors:  Anahita Dastur; Sylvie Beaudenon; Melissa Kelley; Robert M Krug; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

6.  Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification.

Authors:  He-Xin Shi; Kai Yang; Xing Liu; Xin-Yi Liu; Bo Wei; Yu-Fei Shan; Lian-Hui Zhu; Chen Wang
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

7.  Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.

Authors:  Joris Hemelaar; Anna Borodovsky; Benedikt M Kessler; David Reverter; Julie Cook; Nagamallesawari Kolli; Tudev Gan-Erdene; Keith D Wilkinson; Grace Gill; Christopher D Lima; Hidde L Ploegh; Huib Ovaa
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Authors:  Min-Jung Kim; Sun-Young Hwang; Tadaatsu Imaizumi; Joo-Yeon Yoo
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

9.  Antiviral Properties of ISG15.

Authors:  Deborah J Lenschow
Journal:  Viruses       Date:  2010-09-28       Impact factor: 5.818

10.  The ISG15 conjugation system.

Authors:  Larissa A Durfee; Jon M Huibregtse
Journal:  Methods Mol Biol       Date:  2012
View more
  27 in total

Review 1.  How ISG15 combats viral infection.

Authors:  Brendan T Freitas; Florine E M Scholte; Éric Bergeron; Scott D Pegan
Journal:  Virus Res       Date:  2020-05-31       Impact factor: 3.303

Review 2.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

3.  Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Authors:  Tate Tabtieng; Alexei Degterev; Marta M Gaglia
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

4.  Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

Authors:  Gavin Golas; Seung Jin Jang; Nenavath Gopal Naik; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  Virology       Date:  2019-12-30       Impact factor: 3.616

5.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

6.  Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing.

Authors:  Christopher Bianco; Ian Mohr
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 7.  Activation and Evasion of Innate Immunity by Gammaherpesviruses.

Authors:  Philip T Lange; Maria C White; Blossom Damania
Journal:  J Mol Biol       Date:  2021-08-23       Impact factor: 5.469

8.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation by Downregulating UBE1L.

Authors:  Myoung Kyu Lee; Ye Ji Kim; Young-Eui Kim; Tae-Hee Han; Jens Milbradt; Manfred Marschall; Jin-Hyun Ahn
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 10.  Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

Authors:  Danielle L Chappell; Maria C White; Blossom Damania
Journal:  Adv Virus Res       Date:  2020-11-09       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.